PRDM9 and cancer: Epigenetic modifiers, including histone methyltransferases, deoxyribo nucleic acid (DNA) methyltransferases, and mirco ribonucleic acid (miRNA)s, have been clearly linked to cancer progression in various types of cancer (Michalak et al., 2019).